Literature DB >> 11849414

Plasma aminothiol oxidation in chronic hemodialysis patients.

Jonathan Himmelfarb1, Elizabeth McMenamin, Ellen McMonagle.   

Abstract

BACKGROUND: Plasma aminothiols, including homocysteine, cysteine, and glutathione, function as an important extracellular redox system. We examined the plasma aminothiol concentration and redox status in ten chronic hemodialysis patients compared to ten age-matched healthy subjects.
METHODS: Plasma levels of reduced, free oxidized, and protein-bound homocysteine, cysteine, cysteinylglycine, and glutathione were determined using high-pressure liquid chromatography (HPLC).
RESULTS: Total plasma homocysteine, cysteine, and cysteinylglycine levels were significantly elevated in hemodialysis patients before dialysis compared to healthy subjects. Total plasma concentration of cysteine and homocysteine significantly decreased after hemodialysis. The ratio of free oxidized to free reduced homocysteine, cysteine, cysteinylglycine, and glutathione were each significantly elevated before dialysis compared to healthy subjects, and decreased significantly by the end of dialysis. The free oxidized to reduced ratio of cysteine and homocysteine were also significantly correlated with total plasma concentrations.
CONCLUSIONS: Plasma aminothiols are excessively oxidized in uremia, while the hemodialysis procedure is restorative of redox status. Oxidized aminothiols are candidate uremic toxins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849414     DOI: 10.1046/j.1523-1755.2002.00151.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Correction of hyperphosphatemia suppresses cardiac remodeling in uremic rats.

Authors:  Ai Yamazaki-Nakazawa; Masahide Mizobuchi; Hiroaki Ogata; Chiaki Kumata; Fumiko Kondo; Naoko Ono; Fumihiko Koiwa; Susumu Uda; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2013-06-06       Impact factor: 2.801

2.  Kinetic analysis of covalent binding between N-acetyl-L-cysteine and albumin through the formation of mixed disulfides in human and rat serum in vitro.

Authors:  Daisuke Harada; Shinsuku Naito; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

3.  Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: application to studies of oxidative stress.

Authors:  Thomas D Nolin; M Elizabeth McMenamin; Jonathan Himmelfarb
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-21       Impact factor: 3.205

4.  Obesity, diabetes and survival in maintenance hemodialysis patients.

Authors:  Serpil M Deger; Charles D Ellis; Ahuia Bian; Ayumi Shintani; T Alp Ikizler; Adriana M Hung
Journal:  Ren Fail       Date:  2014-01-28       Impact factor: 2.606

Review 5.  [Atherosclerosis and uremia: signifance of non-traditional risk factors].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

6.  Glutathione redox potential is low and glutathionylated and cysteinylated hemoglobin levels are elevated in maintenance hemodialysis patients.

Authors:  Khaled Khazim; Daniela Giustarini; Ranieri Rossi; Darlene Verkaik; John E Cornell; Sue E D Cunningham; Maryam Mohammad; Kara Trochta; Carlos Lorenzo; Franco Folli; Shweta Bansal; Paolo Fanti
Journal:  Transl Res       Date:  2013-01-17       Impact factor: 7.012

7.  Dietary Intake of Proteins and Calories Is Inversely Associated With The Oxidation State of Plasma Thiols in End-Stage Renal Disease Patients.

Authors:  Paolo Fanti; Daniela Giustarini; Ranieri Rossi; Sue E D Cunningham; Franco Folli; Khaled Khazim; John Cornell; Elena Matteucci; Shweta Bansal
Journal:  J Ren Nutr       Date:  2015-07-31       Impact factor: 3.655

8.  Stem cells: the next therapeutic frontier.

Authors:  H David Humes
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

9.  Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.

Authors:  Jonathan Himmelfarb; T Alp Ikizler; Charles Ellis; Pingsheng Wu; Ayumi Shintani; Sanjay Dalal; Mark Kaplan; Michel Chonchol; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 10.121

10.  Treatment of chronic hemodialysis patients with low-dose fenofibrate effectively reduces plasma lipids and affects plasma redox status.

Authors:  Agnieszka Makówka; Przemysław Dryja; Grażyna Chwatko; Edward Bald; Michał Nowicki
Journal:  Lipids Health Dis       Date:  2012-07-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.